Direct Doctor Supply has spent over a decade as a bridge between manufacturers and the clinics, medspas, and individual buyers who make use of a wide range of cosmetic and medical products. A lot of information moves across that bridge, as we share clinical, regulatory, and technical details regarding dermal fillers, botulinum toxin, orthopedic injections, and mesotherapy solutions. The people reading Direct Doctor Supply are making real decisions with the information that we share, as they decide what to stock, what to inject, and what to trust.
That’s the starting point for how we think about content. We deliberately favor precision over volume, as we are not on online magazine, but rather trusted procurement platform. Our content revolves around verifiable claims and specific documentation, such that a pharmacist, a nurse injector, or a first-time buyer can make nuanced decisions. It is our job to save the reader from untangling marketing language from medical fact. Accuracy and readability don’t necessarily create tension when we write on specific topics, for a specific audience.
Who We Create Content For
Our catalogue serves two overlapping groups, and we write with both in mind rather than picking one. Licensed medical and aesthetic professionals use our content to evaluate products at a technical level. This includes physicians, nurse practitioners, dermatologists, and clinic buyers who scrutinize mechanism, formulation, regulatory status, or how one brand compares to another. Individual buyers, who can purchase certain device categories directly, rely on the same pages to understand what a product is, how it’s used in practice, and what to expect, before they visit a specialist.
Rather than running two separate content tracks, we write each page for the audience that will benefit from it, as we’re careful not to let technical depth slide into jargon, or simplicity slide into vagueness.
How We Evaluate Medical Information
Not everything written about aesthetic medicine carries the same weight, and we try to be honest about that distinction. A finding from a randomized controlled trial is not the same thing as a manufacturer’s marketing claim, and a well-established clinical consensus is not the same thing as an emerging technique that a handful of practitioners are experimenting with. We aim to be clear about the relevance of sources.
In practice, that means:
- separating what a product is approved for from how it may be used in evolving clinical practice
- noting when evidence on a topic is limited, mixed, or still developing rather than presenting it as settled
- describing benefits and risks in proportion to what the evidence actually shows.
We also try to keep opinion visibly separate from evidence. A practitioner’s preference for one injection technique over another, or a view on which brand “feels” more reliable in practice, can be genuinely useful context. However, it isn’t clinical proof, and we don’t dress it up as one. Where that kind of practical, experience-based insight makes its way into a page, we distinguish between opinion and actual trial data.
We also keep a clear distinction between editorial pieces, where claims are made on the basis of comparison, clinical feedback, and analyses of use cases, from content that covers brand catalogs. When covering brands, we aim to accurately represent what their product lineup includes, and whether or not there is relevant literature on those specific products, as well as the active substances or ingredients which constitute them. This is how we cover brands like Hyalgan®, Orthovisc®, Radiesse®, Restylane®, Monovisc®, Juvederm®, Stylage®, Euflexxa®, Institute BCN, and many others, across dozens of categories.
Our Standards for Accuracy
Every clinical or regulatory statement we publish is expected to trace back to a source we can point to. That’s a baseline that’s been well established at Direct Doctor Supply. We also work at rewriting dense material into language a busy clinician or a first-time buyer can absorb quickly, without cutting corners on what’s actually true.
Because we ship worldwide, we’re also careful about geography. A product approved in one market isn’t necessarily approved everywhere, and we try to be very precise. Pages aimed at licensed professionals carry disclaimers matched to who’s reading them.
None of this is static wording we set once and forget. As new studies come out, as regulatory bodies update guidance, or as a manufacturer revises its documentation, the standard is that our content reflects the current picture.
Evidence and Source Selection
We lean toward primary sources over secondary summaries. We always cite the original clinical trial rather than an article describing it, and always point to the regulatory filing rather than a press release about it. In order of how much weight we give each source:
Primary literature: peer-reviewed studies, systematic reviews and meta-analyses, and clinical trial registry data, which we treat as the strongest available evidence for a clinical claim.
Regulatory records: prescribing information, Summary of Product Characteristics (SmPC) documents, and public assessment reports from bodies including the FDA, EMA, Health Canada, and TGA, in relevance of the markets our buyers order from.
Manufacturer documentation: technical datasheets and instructions for use (IFUs), which we treat as authoritative for product specifications but not as a substitute for independent clinical evidence.
Professional consensus: positions and guidance from bodies such as IMCAS, ISAPS, and the International Peptide Society, which we use to add context around how practitioners actually apply the evidence, rather than as standalone proof of a claim.
Review and Quality Assurance
Content on Direct Doctor Supply isn’t published immediately, but follows the structured editorial approach described below:
1. Writers with backgrounds in medical communications draft against a brief that sets out the topic and the audience.
2. Each claim is derived from the relevant sources, with proper citation employed throughout.
3. Once the draft is ready, and editor with medical communication background checks that every clinical and regulatory claim matches the source behind it, and that paraphrasing hasn’t drifted from what the original actually said. The goal is to produce a credible document where nothing is generalized beyond the evidence.
The editor acts as a reviewer and as such is not actively engaged in the content creation process. For more about roles and responsibilities, check our editorial team.
Because Direct Doctor Supply also stands behind the authenticity of what we ship, through verified manufacturers, traceable packaging, and licensed distributors, any content that touches sourcing or product origin gets checked against what our procurement team can actually substantiate. This review step is not something that content sites need to think about, but is a fairly central one for a platform such as ours.
Keeping Information Current
Our process doesn’t represent a single checkpoint that each piece has to pass through only once. Instead, we employ ongoing quality control, as the same standards that apply before a page first goes live continue to apply to it for as long as it stays on the site.
Medical and regulatory information doesn’t stay still, and our content reflects that. Pages are reviewed periodically, with priority given to anything with emergent clinical evidence, a change in a product’s regulatory status, or an update to manufacturer specifications or documentation. When a page is meaningfully revised, beyond small copyedits and formatting, we update its modified date.
Transparency and Corrections
We’d rather hear about a mistake from a reader than not hear about it at all. If something on this site, whether a clinical claim, a regulatory detail, or a specification, looks wrong, we want to know.
Reach our editorial team at editorial@directdoctorsupply.com with the page in question, what you believe is inaccurate, and a source if you have one. Correction requests are reviewed promptly and incorporated when warranted. Where we conclude the existing content holds up, we’ll reply back and explain our reasoning.
Commercial Independence
We sell the products we write about, which makes editorial independence something we have to actively protect rather than assume. Writers and editors aren’t compensated based on how well a product sells, and decisions about what a page claims, what it cites, and whether it needs correcting are made apart from our commercial and procurement teams.
Marketing language has its place on this site, but not within the content which we hold to high standards. A product description written to sell is allowed to be persuasive, whereas a clinical claim is not allowed to be anything other than accurate.
If you have questions about how we work, please write to us at editorial@directdoctorsupply.com